- Profile
- Personal Information
- Publications
Experts in Pharmaceutical Sciences
Rabaa M. Al-Rousan Hamed I. Aly Daniela Z. Bazan Adam Brown Wei Minjie Juan F. Castro Dr. Manoj Kumar Barthwal Dr Jagavelu Kumaravelu Zakaria Abd Elmageed Burton M Altura BENJAMIN E. BLASS Charlotte Farris Michael Borenstein prof. dr. A.J.R. Heck Vibha Rani Reza Fassihi Shweta Dang MARC ILIES Adriana Ribeiro Silva SWATI NAGAR View MoreDr. Bernd Seizinger, MD PhD
Chairman
Pharmaceuticals
Oxford BioTherapeutics
Switzerland
Dr. Bernd Seizinger has held a number of senior executive and board positions in both U.S. and European biotech and pharmaceutical companies including: President & CEO of GPC Biotech (Germany/U.S.); VP Oncology Drug Discovery & Molecular Genetics, and VP Corporate and Academic Alliances at Bristol-Myers-Squibb (U.S.); EVP/CSO of Genome Therapeutics (U.S.); CEO/Chairman of CryptoMedix (U.S.); Executive Chairman/Chairman of Aprea (Sweden/U.S.); and Executive/Chairman of Opsona (Ireland). Prior to his corporate appointments, Dr Seizinger held senior faculty positions at Harvard Medical School and Massachusetts General Hospital, and was a Visiting Professor at Princeton University during his tenure at Bristol-Myers Squibb. Dr. Seizinger also served on the board at Santhera Pharmaceuticals Holding AG. Dr. Seizinger received his doctorate degree from the Max-Planck-Institute for Molecular Genetics and a doctorate degree from Ludwig-Maximilians-Universität München.
Molecular Genetics